אובסטין ישראל - עברית - Ministry of Health

אובסטין

perrigo israel agencies ltd - estriol - קרם - estriol 0.1 % - estriol - estriol - for the treatment of vulvo-vaginal complaints related to estrogen deficiency.

אובסטין ישראל - עברית - Ministry of Health

אובסטין

padagis israel agencies ltd, israel - estriol - קרם - estriol 0.1 % - estriol

אורטו ג'נסט פתילה ישראל - עברית - Ministry of Health

אורטו ג'נסט פתילה

j-c health care ltd - estriol 0.5 mg - pessary - estriol - for the treatment of atropic vaginitis and kraurosis vulvea in post menopausal women and for treatment of pruvitis vulvea and dyspareunia when associated with atrophic vaginal epithelium resulting from estrogen deficiency.

וגיפם 10 מקג ישראל - עברית - Ministry of Health

וגיפם 10 מקג

novo nordisk ltd., israel - estradiol hemihydrate - טבליות מצופות פילם - estradiol hemihydrate 10 mcg - estradiol - estradiol - treatment of atrophic vaginitis due to estrogen deficiency in postmenopausal women.

אוורל קונטי ישראל - עברית - Ministry of Health

אוורל קונטי

truemed ltd. - estradiol as hemihydrate; norethisterone acetate - מדבקות - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.

אסטרוג'ל ישראל - עברית - Ministry of Health

אסטרוג'ל

cts ltd - estradiol - ג'ל - estradiol 0.06 %w/w - estradiol - estradiol - hormonal replacement therapy for the treatment of symptoms associated with estrogen deficiency in menopausal women. prevention of postmenopausal osteoporosis in women with an increased risk for osteoporotic fractures and presenting intolerace or a contraindication to others treatments indicated in the prevention of osteoporosis.

אסטרופם 2 מג ישראל - עברית - Ministry of Health

אסטרופם 2 מג

novo nordisk ltd., israel - estradiol as hemihydrate - טבליות מצופות פילם - estradiol as hemihydrate 2 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.

אסטרופם 1 מג ישראל - עברית - Ministry of Health

אסטרופם 1 מג

novo nordisk ltd., israel - estradiol as hemihydrate - טבליות מצופות פילם - estradiol as hemihydrate 1 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.

נובופם ישראל - עברית - Ministry of Health

נובופם

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - טבליות מצופות פילם - estradiol as hemihydrate 1 mg; norethisterone acetate 1 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women with an intact uterus. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis.

אביאנה ישראל - עברית - Ministry of Health

אביאנה

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - טבליות מצופות פילם - estradiol as hemihydrate 0.5 mg; norethisterone acetate 0.1 mg - estradiol, combinations - estradiol, combinations - eviana is indicated for women who have a uterus for the: treatment of moderate to severe vasomotor symptoms associated with menopause. prevention of postmenopausal osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.